Celltrion, Inc. (KRX:068270)
South Korea · Delayed Price · Currency is KRW 190,700
-600 (-0.31%)
At close: Aug 28, 2026
Celltrion Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 4,897,805 | 4,162,495 | 3,557,304 | 2,176,432 | 2,283,967 | 1,893,401 |
Revenue Growth | 30.64% | 17.01% | 63.45% | -4.71% | 20.63% | 2.40% |
Gross Profit Gross Profit Growth | 3,029,878 | 2,467,027 | 1,681,713 | 1,051,869 | 1,032,697 | 1,087,594 |
Operating Income Operating Income Growth | 1,545,713 | 1,164,546 | 492,016 | 651,434 | 647,200 | 744,163 |
Net Income Net Income Growth | 1,576,119 | 1,029,613 | 422,692 | 535,648 | 537,836 | 579,465 |
Earnings Per Share EPS Growth | 6840.22 | 4438.10 | 1786.67 | 3273.16 | 3258.27 | 3472.89 |
EPS Growth | 226.44% | 148.40% | -45.41% | 0.46% | -6.18% | 13.28% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Biopharmaceutical Medicines Biopharmaceutical Medicines Growth | 6,896,771 | 6,033,277 | 6,070,131 | 1,873,430 | 1,937,469 | 1,615,840 |
Chemical Medicines Chemical Medicines Growth | 603,131 | 556,710 | 531,389 | 500,777 | 653,519 | 538,511 |
Other Segments Other Segments Growth | 6,656 | 6,737 | 5,825 | 5,143 | 3,877 | 3,054 |
Adjustments Adjustments Growth | -2,608,753 | -2,434,229 | -3,050,041 | -202,919 | -310,898 | -264,004 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,258,167 | 1,239,107 | 1,143,046 | 757,497 | 594,464 | 1,219,901 |
Total Debt Total Debt Growth | 3,866,738 | 3,729,110 | 2,192,676 | 1,890,420 | 792,332 | 744,356 |
Net Cash (Debt) Net Cash Growth | -2,608,571 | -2,490,004 | -1,049,630 | -1,132,923 | -197,868 | 475,545 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -11319.07 | -10732.04 | -4437.60 | -6922.91 | -1198.75 | 2849.69 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 995,898 | 646,051 | 901,870 | 537,159 | 863.53 | 911,159 |
Capital Expenditures CapEx Growth | -172,827 | -108,224 | -135,059 | -210,046 | -111,169 | -63,379 |
Free Cash Flow Free Cash Flow Growth | 823,072 | 537,827 | 766,812 | 327,112 | -110,305 | 847,780 |
Free Cash Flow Growth | 8.20% | -29.86% | 134.42% | - | - | 221.45% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 61.86% | 59.27% | 47.27% | 48.33% | 45.21% | 57.44% |
Operating Margin | 31.56% | 27.98% | 13.83% | 29.93% | 28.34% | 39.30% |
Pretax Margin | 36.66% | 27.72% | 16.20% | 30.83% | 27.42% | 39.01% |
Profit Margin | 32.18% | 24.73% | 11.88% | 24.61% | 23.55% | 30.60% |
FCF Margin | 16.80% | 12.92% | 21.56% | 15.03% | -4.83% | 44.78% |
| Fiscal Year | Current | FY 2025 |
|---|---|---|
| Period Ending | Aug '26 Aug 30, 2026 | Dec '25 Dec 31, 2025 |
Dividend Per Share Dividend Per Share Growth | 714.286 | 714.286 |
Dividend Per Share Growth | 4.00% | - |
Dividend Yield | 0.37% | 0.41% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 27.88 | 38.46 | 95.50 | 52.22 | 42.77 | 47.62 |
Forward PE | 31.03 | 40.41 | 48.86 | 76.81 | 41.12 | 52.71 |
P/FCF Ratio | 55.61 | 73.63 | 52.64 | 85.51 | - | 32.55 |
PS Ratio | 9.34 | 9.51 | 11.35 | 12.85 | 10.07 | 14.57 |